Use of cannabidiol in the treatment of epilepsy
US10765643B2 · kind B2 · utility
31Cited by
22References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 2015 |
| Grant date | Sep 8, 2020 |
| Priority date | — |
| Expiry date | Oct 14, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of seizures associated with Aicardi Syndrome. In one embodiment the seizures associated with Aicardi Syndrome are convulsive seizures; focal seizures with impairment or infantile spasm. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.